Walk DOC: walking with overground robotic exoskeleton device to increase behavioral responsiveness in patients with disorders of consciousness 2/4/26: modification P00001 transferred the award to…

The Defense Health Agency awarded The Spaulding Rehabilitation Hospital Corporation $777,538 on November 1, 2025, under the Military Medical Research and Development program (CFDA 12.420) to conduct the WALK DOC initiative, which uses robotic exoskeleton technology to improve behavioral responsiveness in patients with disorders of consciousness. The award was transferred to Spaulding from Baylor Scott and White Research via modification on February 4, 2026. Work is performed in Charlestown, Massachusetts, with a period of performance ending October 31, 2028. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative solutions, with typical award periods of three to four years and ranges from $100,000 to $20 million depending on funding priorities and project scope.

Walk DOC: walking with overground robotic exoskeleton device to increase behavioral responsiveness in patients with disorders of consciousness 2/4/26: modification P00001 transferred the award to spaulding rehabilitation hospital corp.